These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37588725)

  • 21. Determinants of multidrug-resistant tuberculosis in São Paulo-Brazil: a multilevel Bayesian analysis of factors associated with individual, community and access to health services.
    Arroyo LH; Yamamura M; Ramos ACV; Campoy LT; Crispim JA; Berra TZ; Alves LS; Alves YM; Dos Santos FL; Souza LLL; Bruce ATI; de Andrade HLP; Bollela VR; Krainski ET; Nunes C; Arcêncio RA
    Trop Med Int Health; 2020 Jul; 25(7):839-849. PubMed ID: 32358845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis in Poland in 2016.
    Korzeniewska-Koseła M
    Przegl Epidemiol; 2018; 72(2):189-205. PubMed ID: 30111079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatial clustering and temporal trend analysis of international migrants diagnosed with tuberculosis in Brazil.
    Arcêncio RA; Berra TZ; Terena NFM; Rocha MP; Ferraz de Araújo Alecrim T; de Souza Kihara FM; Mascarello KC; Martins Sales CM; Maciel ELN
    PLoS One; 2021; 16(6):e0252712. PubMed ID: 34106968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance.
    Hameed S; Ahmad SR; Rahman MAU; Nazir H; Ullah I
    J Glob Antimicrob Resist; 2019 Sep; 18():155-159. PubMed ID: 30910744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015-2018: A retrospective study.
    Xu Y; Li Q; Zhu M; Wu X; Wang D; Luo J; Li Y; Zhong J; Zeng P
    Medicine (Baltimore); 2020 Oct; 99(43):e22608. PubMed ID: 33120748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
    Cornejo Garcia JG; Alarcón Guizado VA; Mendoza Ticona A; Alarcon E; Heldal E; Moore DAJ
    PLoS One; 2018; 13(12):e0206658. PubMed ID: 30513085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.
    Shah I; Shah F
    Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug susceptibility patterns of Mycobacterium tuberculosis and clinical outcomes of drug-resistant tuberculosis at Srinagarind Hospital, a tertiary care center in northeastern Thailand.
    Reechaipichitkul W; Tubtim S; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1154-62. PubMed ID: 22299441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017.
    Glasauer S; Altmann D; Hauer B; Brodhun B; Haas W; Perumal N
    PLoS One; 2019; 14(6):e0217597. PubMed ID: 31188848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
    Pai H; Ndjeka N; Mbuagbaw L; Kaniga K; Birmingham E; Mao G; Alquier L; Davis K; Bodard A; Williams A; Van Tongel M; Thoret-Bauchet F; Omar SV; Bakare N
    BMC Infect Dis; 2022 Nov; 22(1):870. PubMed ID: 36414938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of tuberculosis: epidemiology, resistance and monitoring.
    Bang D
    Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological aspects of tuberculosis in children and adolescents in Rio de Janeiro.
    Matos TP; Kritski AL; Ruffino Netto A
    J Pediatr (Rio J); 2012 Jul; 88(4):335-40. PubMed ID: 22914971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study.
    Pan Y; Yu Y; Yi Y; Dou X; Lu J; Zhou L
    BMC Infect Dis; 2023 Mar; 23(1):162. PubMed ID: 36922787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil.
    Ramalho DMP; Miranda PFC; Andrade MK; Brígido T; Dalcolmo MP; Mesquita E; Dias CF; Gambirasio AN; Ueleres Braga J; Detjen A; Phillips PPJ; Langley I; Fujiwara PI; Squire SB; Oliveira MM; Kritski AL;
    BMC Infect Dis; 2017 Aug; 17(1):571. PubMed ID: 28810911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010.
    Moore BK; Anyalechi E; van der Walt M; Smith S; Erasmus L; Lancaster J; Morris S; Ndjeka N; Ershova J; Ismail N; Burton D; Menzies H
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):663-9. PubMed ID: 25946356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
    Shivekar SS; Kaliaperumal V; Brammacharry U; Sakkaravarthy A; Raj CKV; Alagappan C; Muthaiah M
    Sci Rep; 2020 Oct; 10(1):17552. PubMed ID: 33067551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of centralized versus decentralized tuberculosis treatment services in Southern Brazil, 2006-2015.
    Scheffer MC; Prim RI; Wildner LM; Medeiros TF; Maurici R; Kupek E; Bazzo ML
    BMC Public Health; 2018 Apr; 18(1):554. PubMed ID: 29699537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.